This Biotech’s Drug Could Treat Hot Flashes. The Stock Is Up 34% on Good News.

Momentum

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Who reported it (8)

• 
  Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today? TradingView · 42d ago
• 
  AbCellera stock soars on ‘off the chart’ trial results from hot flash treatment for menopausal women The Globe and Mail · 42d ago
• 
  AbCellera Stock Jumps 33% on a Positive Menopause Trial Yahoo Finance · 42d ago
• 
  Hot-Flash Drug Trial Result Sends AbCellera Up as Much as 41% Bloomberg.com · 42d ago
• 
  AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice Fierce Biotech · 42d ago
• 
  AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile Business Wire · 42d ago
• 
  AbCellera’s ABCL-635 Cuts Menopause Hot Flashes 83% in Phase II Trial Yahoo Finance · 42d ago
• 
  This Biotech’s Drug Could Treat Hot Flashes. The Stock Is Up 34% on Good News. Barron's · 42d ago broke it first

From around our network

• Why Larry Ellison's Scrapped $7.5 Billion Stock Sale Was Never a Secret daybreakwire.com
• The Key Stat That Could Define Every NBA Team’s 2026-27 Season world-today-news.com

Related trends